Maninder Ahluwalia

Dr. Maninder Ahluwalia serves as a Principal Lecturer in Clinical/Human Genetics at Cardiff Metropolitan University's Cardiff School of Sport & Health Sciences. His academic work bridges the fields of human genetics, nutrition science, and molecular biology with a particular focus on how genetic factors interact with dietary components.

Dr. Ahluwalia's research interests center on nutrigenetics and nutrigenomics, chrononutrition, inflammation mechanisms, and hematological processes. His work explores how genetic variations influence individual responses to nutrients, the timing of food intake on metabolic health, and the molecular mechanisms underlying inflammatory responses to natural compounds. His research has important implications for personalized nutrition approaches and understanding blood cell development processes.

Analysis of Dr. Ahluwalia's publication record reveals a consistent focus on the intersection of genetics, nutrition, and cellular mechanisms. His research spans from fundamental molecular investigations of gene expression and signaling pathways to applied research examining how natural compounds affect cellular processes relevant to human health. The work shows particular strength in understanding how dietary components influence genetic expression and cellular function, with implications for chronic disease prevention and management.

Dr. Ahluwalia's research contributes to Cardiff Met's Health and Human Performance Global Academy, which takes a holistic view of human performance aiming to improve individuals for societal benefit. His work aligns with the university's research excellence as demonstrated in the REF 2021 assessment where Cardiff Met showed 70% of research as Internationally Excellent or World Leading.

His laboratory investigations have examined macrophage polarization, megakaryocyte development, and the molecular mechanisms of natural compounds. This work has contributed to understanding cellular processes relevant to inflammation, cardiovascular health, and blood disorders, demonstrating the translational potential of basic science research to address important health challenges.